Omicron BA.1 breakthrough infection in BNT162b2-vaccinated individuals primarily expands a broad BMEM cell repertoire against conserved S glycoprotein and RBD epitopes, rather than inducing strictly Omicron BA.1-specific BMEM cells. This evidence concerns the gene CFB and infection.